In this study, we mainly assessed the predictive value of circulating cytokine levels in Chinese patients with advanced NSCLC following ICI treatment and found that the circulating cytokine CXCL12 level may help predict DCB, PFS, and OS. This evidence concerns the gene CXCL12 and non-small cell lung carcinoma.